Global Health Ltd

NSE:MEDANTA (India)  
₹ 1122.40 (+4.23%) Jun 5
69.89
P/B:
11.49
Market Cap:
₹ 301.65B ($ 3.62B)
Enterprise V:
₹ 297.58B ($ 3.57B)
Volume:
836.87K
Avg Vol (2M):
402.42K
Volume:
836.87K
Avg Vol (2M):
402.42K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Global Health Ltd ( NSE:MEDANTA ) from 2022 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Global Health stock (NSE:MEDANTA) PE ratio as of Jun 05 2024 is 69.89. More Details

Global Health Ltd (NSE:MEDANTA) PE Ratio (TTM) Chart

To

Global Health Ltd (NSE:MEDANTA) PE Ratio (TTM) Historical Data

Total 406
  • 1
  • 2
  • 3
  • 4
  • 5
Global Health PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-06 63.1 2024-04-05 76.8
2024-06-05 63.1 2024-04-04 76.2
2024-06-04 60.5 2024-04-03 75.2
2024-06-03 65.6 2024-04-02 74.8
2024-05-31 67.0 2024-04-01 74.8
2024-05-30 65.2 2024-03-29 74.3
2024-05-29 66.8 2024-03-28 74.3
2024-05-28 69.2 2024-03-27 79.5
2024-05-27 68.8 2024-03-26 76.6
2024-05-24 66.6 2024-03-25 76.0
2024-05-23 67.5 2024-03-22 76.0
2024-05-22 69.7 2024-03-21 73.0
2024-05-21 75.0 2024-03-20 71.7
2024-05-20 79.9 2024-03-19 71.8
2024-05-18 78.9 2024-03-18 70.3
2024-05-17 79.9 2024-03-15 66.5
2024-05-16 78.4 2024-03-14 67.4
2024-05-15 78.8 2024-03-13 68.3
2024-05-14 79.4 2024-03-12 71.5
2024-05-13 78.1 2024-03-11 73.5
2024-05-10 79.4 2024-03-08 74.5
2024-05-09 78.6 2024-03-07 74.5
2024-05-08 79.5 2024-03-06 74.5
2024-05-07 78.8 2024-03-05 74.0
2024-05-06 78.7 2024-03-04 74.8
2024-05-03 79.2 2024-03-01 77.1
2024-05-02 80.1 2024-02-29 81.0
2024-05-01 81.2 2024-02-28 85.6
2024-04-30 81.2 2024-02-27 85.6
2024-04-29 82.0 2024-02-26 85.2
2024-04-26 81.3 2024-02-23 88.3
2024-04-25 80.8 2024-02-22 88.2
2024-04-24 81.1 2024-02-21 85.0
2024-04-23 78.6 2024-02-20 83.1
2024-04-22 80.0 2024-02-19 82.8
2024-04-19 78.9 2024-02-16 85.2
2024-04-18 77.2 2024-02-15 82.5
2024-04-17 77.9 2024-02-14 78.5
2024-04-16 77.9 2024-02-13 80.1
2024-04-15 77.6 2024-02-12 79.9
2024-04-12 78.6 2024-02-09 75.3
2024-04-11 80.1 2024-02-08 74.7
2024-04-10 80.1 2024-02-07 73.3
2024-04-09 78.4 2024-02-06 73.3
2024-04-08 77.7 2024-02-05 72.0

Global Health Ltd (NSE:MEDANTA) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.